|
YASUKAWA Kumi
Department School of Medicine(Yachiyo Medical Center), School of Medicine Position Associate Professor |
|
| Article types | Original article |
| Language | English |
| Peer review | Peer reviewed |
| Title | Sivelestat Sodium Hydrate Treatment for refractory Kawasaki Disease Patients. |
| Journal | Formal name：Pediatrics international : official journal of the Japan Pediatric Society Abbreviation：Pediatr Int ISSN code：(1442-200X)1328-8067(Linking) |
| Domestic / Foregin | Foregin |
| Volume, Issue, Page | 61(5),pp.438-443 |
| Author and coauthor | EBATA Ryota†*, YASUKAWA Kumi, NAGAI Kazue, SAITO Yuko, HIGASHI Kouji, HOMMA Jun, TAKADA Nobuyuki, TAKECHI Fumie, SAITO Naoki, KOBAYASHI Hironobu, OKUNUSHI Kentaro, HAMADA Hiromichi, KOHNO Yoichi, HANAOKA Hideki, SHIMOJO Naoki |
| Publication date | 2019/05 |
| Summary | Additional IVIG combined with SSH as a second-line therapy for KD patients who were refractory to initial IVIG therapy was safe and well tolerated and could be a promising option for severe KD patients. Further investigations are expected to clarify safety and timing of SSH treatment for patients with KD. This article is protected by copyright. All rights reserved. |
| DOI | 10.1111/ped.13851 |
| PMID | 30916859 |